This Annual Event is Considered the Premier Medtech Investment Conference in Europe
The MedTech Strategist, a key information and investment conferences provider serving the global medical technology industry, announces that partnering via the Jujama app is now open for The MedTech Strategist Innovation Summit Dublin 2017 conference, that begins tomorrow, April 25, 2017 and continues through the 27th at The Shelbourne Hotel, Dublin, Ireland. This exceptional two-and-a-half-day event, built upon The MedTech Strategist’s 25+-year legacy of top-tier medtech investment and networking events, including the highly regarded Dublin conferences, will feature presentations by 42+ early-stage medical device companies from around the world, along with thought-leading keynote speakers, insightful and timely strategic, venture capital, entrepreneur and new funds panel discussions, and spotlight sessions all providing candid insight on topics of utmost importance to all stakeholders in the rapidly evolving global device marketplace.
Dublin 2017 is hosted by The MedTech Strategist, along with top-tier supporters including Platinum Sponsors Johnson & Johnson, Medtronic, Seroba, Enterprise Ireland, EY, Medmarc, and Eugene F. Collins; Gold Sponsors AdvaMed, CBSET, Databean, genae, Greenleaf Health, ICON, IMMR, iO Life Science, the Irish Medtech Association/Ibec, Lightstone Ventures and PMI; and Media Partners Biotechgate/Venture Valuation, Medtech Engine, and MedTech Europe. Full event and registration information is available at the Dublin 2017 website.
Confirmed Keynote Speakers at Dublin 2017 include Peter Fitzgerald, MD, PhD, Professor (Research) of Medicine (Cardiovascular), Emeritus, Stanford University Medical Center; Josh Makower, General Partner, NEA; Stephen Oesterle, MD, Venture Partner, NEA; Charles Simonton, MD, Divisional Vice President, Medical Affairs and Chief Medical Officer, Vascular, Abbott Laboratories; and David Steinhaus, Medical Director and Vice President, Cardiac Rhythm Disease Management (CRDM), Medtronic. The event will also feature the popular MedTech Innovator start-up competition, hosted by Paul Grand, MedTech Innovator CEO, along with sessions including “The Most Pervasive Problems in Trial Design – And How to Fix Them,” by sponsoring company ICON Plc, and “Trends Shaping the Global MedTech Industry,” by sponsor EY, and “The State of the Medical Device Regulatory Landscape,” presented by sponsors AdvaMed and MedTech Europe.
“We’re extremely pleased with the way this conference has grown over the past several years, not just in terms of attendance, but also in its ability to attract outstanding keynote speakers, panelists, and start-ups, creating a compelling agenda,” says David Cassak, Co-Editor-in-Chief, The MedTech Strategist, organizers of the Dublin 2017 conference. Adds Steve Levin, Co-Editor-in-Chief, “The richness of the European medtech community is fully on display at this conference. It’s been amazing to see executives from big and small companies and investors come together to share ideas and explore opportunities.”
The MedTech Strategist, an information and investment conferences provider focused exclusively on the under-served medtech market, is led by managing partners and co-editors-in-chief David Cassak and Stephen Levin, along with a seasoned editorial team. The company launched The MedTech Strategist, a publication broadly covering the most important topics and trends in medical devices today, in September 2014. Featuring a wide range of editorial offerings — from interviews with industry leaders to stories on leading companies, profiles of ground-breaking start-ups and analyses of dynamic clinical markets and technology trends — The MedTech Strategist, in 18 issues per year, explores how innovation plays out in all of its various forms — clinical, technological, business model, marketplace, and financing — in the global medical device arena. For subscription information and current offers, as well as coverage in the 385+ articles published to date, please visit The MedTech Strategist website.
Director of Commercial Development
Innovation In Medtech, LLC
888-202-5939 or 480-985-9512